Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2006
Errors in Text and Acknowledgment. In the Study by Mentink et al titled “Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial,” published in the May issue of the ARCHIVES (2006;142:570-576), the number of oral doses was inadvertently misstated in the “Study Protocol” subsection of the “Methods” section on page 571. In the second paragraph, the fourth sentence should have read as follows: “During pulse visits, 6 oral tablets of 50 mg of dexamethasone, or 6 tablets of placebo (which were both specially produced to be identical in taste and smell and were tested for this study)18 were given on 3 consecutive days every 4 weeks.” In addition, the academic degree for Dédée Murrell, in the last line of the Acknowledgment on page 576, should have been listed as MD. Online versions of this article on the Archives of Dermatology Web site were corrected on May 23, 2006.
Errors in Text and Acknowledgment in: Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial. Arch Dermatol. 2006;142(8):1014. doi:10.1001/archderm.142.8.1014